We report here studies of the antitumor action of a 4H-aminochromene compound in a xenograft model of ALK-expressing lung adenocarcinoma in humanized nude BALB/c mice. These studies showed that intragastric administration of the compound produced dose-dependent reductions in tumor size and metastasis frequency, with increases in the survival of xenograft-carrying animals. The effect of the compound is based on suppression of the expression of receptor tyrosine kinase and β3-tubulin in tumor tissues and activation of caspase-3-dependent programmed tumor cell death. The results allow the 4H-aminochromene compound AKh-554 to be regarded as having potential for development of molecularly targeted drugs.
Similar content being viewed by others
References
A. Buzdin, M. Sorokin, A. Glusker, et al., J. Clin. Oncol., 35(15), e23142 (2017); https://doi.org/10.1200/JCO20173515_supple23142.
S. A. Patil, J. Wang, X. S. Li, et al., Bioorg. Med. Chem. Lett., 22(13), 4458 – 4461 (2012); https://doi.org/10.1016/jbmcl201204074.
A. Feliciano, O. Gómez-García, C. H. Escalante, et al., Pharmaceuticals (Basel), 14(11), 1110 (2021); https://doi.org/10.3390/ph14111110.
W. Kemnitzer, J. Drewe, S. Jiang, et al., J. Med. Chem., 51(3), 417 – 423 (2008); https://doi.org/10.1021/jm7010657.
Russian Federation Patent 2674987, Byull. 35 (2018).
K. Kita, K. Fukuda, H. Takahashi, et al., Cancer Sci., 110(10), 3215 – 3224 (2019); https://doi.org/10.1111/cas14171.
L. Carbone, PLoS One, 6, e21578 (2011).
P. Girard, D. Verniers, M. C. Coppé, et al., Eur. J. Pharmacol., 584, 263 – 271 (2008).
E. V. Blinova, M. O. Dudina, I. R. Suslova, et al., J. Adv. Pharm. Tech. Res., 9(4), 130 – 134 (2018).
S. A. Glanz, Primer of Biostatistics, McGraw Hill, New York (1993).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 56, No. 1, pp. 15 – 18, January, 2022.
Rights and permissions
About this article
Cite this article
Samyshina, E.A., Blinova, E.V., Kudryavtsev, M.Y. et al. Preparation and Mechanism of the Antitumor Action of a 4H-Aminochromene Compound. Pharm Chem J 56, 12–15 (2022). https://doi.org/10.1007/s11094-022-02593-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-022-02593-3